Caribou Biosciences, Inc. (CRBU) Tops Q4 EPS by 4c

Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q4 EPS of ($0.28), $0.04 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $3.94 million versus the consensus estimate of $2.17 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• CrowdStrike posts record ARR growth, raises full-year outlook
• C3.ai (AI) Tops Q4 EPS by 5c, Beats on Revenue; Offers FY27 Revenue Guidance